Status | Study |
Recruiting |
Study Name: Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2016-11-02 Interventions: Biological: HYQVIA Other Names: IGI 10% with rHuPH20 Immune Gl |
Not yet recruiting |
Study Name: Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2016-08-29 Interventions: Procedure: Muscle Magnetic Resonance Imaging (RMI) evaluation |
Recruiting |
Study Name: Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2015-09-11 Interventions: Biological: HYQVIA Dosing regi |
Recruiting |
Study Name: IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2015-03-13 Interventions: Drug: Intravenous Immunoglobulin The decision to treat with IVIg will be entirely at the discretion of t |
Recruiting |
Study Name: Subcutaneous Immunoglobulin for CIDP Condition: Chronic Inflammatory Demyelinating Polyneuropathy Date: 2014-12-12 Interventions: Drug: Immune Globulin Subcutaneous (Human) Patients who have CIDP and are on IVIG will be allowed in the |
Recruiting |
Study Name: Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2014-12-11 Interventions: Drug: I10E Patients who met all eligibility criteria will receive 0.5 g/kg of IMP every 3 weeks during 4 |
Recruiting |
Study Name: Efficacy and Safety Study of I10E in Treatment of Patients With CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2014-11-13 Interventions: Drug: I10E Patients who meet all eligibility criteria will |
Recruiting |
Study Name: sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Date: 2014-10-09 Interventions: Procedure: Lumbar puncture Lum |
Active, not recruiting |
Study Name: Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Condition: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Date: 2014-01-03 Interventions: Biological: IgPro20 |
Completed |
Study Name: MRI in Diagnosing and Monitoring CIDP Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Date: 2013-12-06 |